Market Cap: $128.84B
Market Cap: $128.84B
Open
$83.25
Prev. Close
$102.88
High
$83.38
Low
$81.41
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world.
Medtronic Plc trades on the New York Stock Exchange under the ticker MDT, priced in USD.
Medtronic Plc has a market capitalisation of $128.84B, based on its latest share price.
MDT trades at 24.18 times its trailing 12-month earnings.
Over the past 52 weeks MDT has traded between $73.31 and $106.33.
Yes. Medtronic Plc's dividend yields 2.89% at the current share price, paying out 70% of its earnings.
Profitable, with a net margin of 13.9% over the last 12 months.
The analyst consensus rating for MDT is Buy. Analysts' average 12-month price target of $102.13 implies 1% upside.
Geoffrey Straub Martha is the CEO of Medtronic Plc, which is headquartered in Galway.
Generated automatically from reported financial data. General information only, not financial advice.

Medtronic plc ( MDT ) continues to position itself as a leader in healthcare technology through its commitment to innovation and strategic partnerships, bolstered by recent impressive financial perfor…

Medtronic (Ticker: MDT) is gaining significant recognition due to its innovative advancements, particularly with the recent FDA approval of the Symplicity Spyral renal denervation system. This new tec…

Medtronic Plc (Ticker: MDT) achieves a significant milestone with the recent FDA 510(k) clearance for its Nellcor pulse oximetry system. This innovative device incorporates the Nell-EQ intelligent pro…

In recent developments, Medtronic Plc (Ticker: MDT) strengthens its position in the neurovascular market through the acquisition of Scientia Vascular, a company specializing in advanced medical device…